Re: Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers Response

被引：0
|
作者：
Narod, Steven A. [1 ]
机构：
[1] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 04期
关键词：
ORAL-CONTRACEPTIVES;
D O I：
10.1093/jnci/djn474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 278
页数：2
相关论文
共 50 条
  • [41] Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Mitchell, G
    Antoniou, AC
    Warren, R
    Peock, S
    Brown, J
    Davies, R
    Mattison, J
    Cook, M
    Warsi, I
    Evans, DG
    Eccles, D
    Douglas, F
    Paterson, J
    Hodgson, S
    Izatt, L
    Cole, T
    Burgess, L
    Eeles, R
    Easton, DF
    CANCER RESEARCH, 2006, 66 (03) : 1866 - 1872
  • [42] Oral Contraceptives and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Figueiredo, Jane C.
    Haile, Robert W.
    Bernstein, Jonine L.
    CURRENT BREAST CANCER REPORTS, 2009, 1 (03) : 139 - 147
  • [43] Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Phillips, Kelly-Anne
    Milne, Roger L.
    Rookus, Matti A.
    Daly, Mary B.
    Antoniou, Antonis C.
    Peock, Susan
    Frost, Debra
    Easton, Douglas F.
    Ellis, Steve
    Friedlander, Michael L.
    Buys, Saundra S.
    Andrieu, Nadine
    Nogues, Catherine
    Stoppa-Lyonnet, Dominique
    Bonadona, Valerie
    Pujol, Pascal
    McLachlan, Sue Anne
    John, Esther M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    Tollenaar, Rob A. E. M.
    Goldgar, David E.
    Terry, Mary Beth
    Caldes, Trinidad
    Weideman, Prue C.
    Andrulis, Irene L.
    Singer, Christian F.
    Birch, Kate
    Simard, Jacques
    Southey, Melissa C.
    Olsson, Hakan L.
    Jakubowska, Anna
    Olah, Edith
    Gerdes, Anne-Marie
    Foretova, Lenka
    Hopper, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3091 - 3099
  • [44] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [45] Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, J
    Lubinski, J
    Lynch, HT
    Neuhausen, SL
    Ghadirian, P
    Isaacs, C
    Weber, B
    Kim-Sing, C
    Foulkes, WD
    Gershoni-Baruch, R
    Ainsworth, P
    Friedman, E
    Daly, M
    Garber, JE
    Karlan, B
    Olopade, OI
    Tung, N
    Saal, HM
    Eisen, A
    Osborne, M
    Olsson, H
    Gilchrist, D
    Sun, P
    Narod, SA
    CANCER CAUSES & CONTROL, 2005, 16 (06) : 667 - 674
  • [46] Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
    Antoniou, Antonis C.
    Shenton, Andrew
    Maher, Eamonn R.
    Watson, Emma
    Woodward, Emma
    Lalloo, Fiona
    Easton, Douglas F.
    Evans, D. Gareth
    BREAST CANCER RESEARCH, 2006, 8 (06)
  • [47] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [48] Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer
    Kuschel, B
    Lux, MP
    Goecke, TO
    Beckmann, MW
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2000, 9 (03) : 139 - 150
  • [49] Survival in Norwegian BRCA1 mutation carriers with breast cancer
    Hagen, Anne Irene
    Tretli, Steinar
    Maehle, Lovise
    Apold, Jaran
    Veda, Nina
    Moller, Pal
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2009, 7
  • [50] Management of breast cancer in BRCA1/2 mutation carriers
    Eeles, RA
    Camplejohn, R
    Peacock, J
    McMillan, T
    DISEASE MARKERS, 1999, 15 (1-3) : 204 - 204
12345